Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chisholm

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Frontiers in Oncology|December 12, 2019
A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of RhabdomyosarcomasSusanne A Gatz, Ewa Aladowicz, Michela Casanova, et al.
Radiology|August 30, 2013
Response assessment in pediatric rhabdomyosarcoma: can response evaluation criteria in solid tumors replace three-dimensional volume assessments?Reineke A Schoot, Kieran McHugh, Rick R van Rijn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapyJulia C Chisholm, Julien Marandet, Annie Rey, et al.
Pediatric Blood & Cancer|May 6, 2016
Response Assessment in Paediatric Phase I Trials According to RECIST Guidelines: Survival Outcomes, Patterns of Progression and Relevance of Changes in Tumour MeasurementsFernando Carceller, Francisco J Bautista, Lucy A Fowkes, et al.
Annals of Surgery|June 1, 1974
The relationship of circulating endogenous endotoxin to hemorrhagic shock in the baboonC M Herman, A R Kraft, K R Smith, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|November 24, 1999
A standardized letter of recommendation for residency applicationS M Keim, J A Rein, C Chisholm, et al.
Pediatric Blood & Cancer|January 20, 2018
BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanomaJulia C Chisholm, Jozef Suvada, Ira J Dunkel, et al.
Pediatric Blood & Cancer|December 10, 2024
Treatment of Pediatric, Adolescent, and Young Adult Patients With Fusion-Positive Alveolar Rhabdomyosarcoma Infiltrating Regional Lymph Nodes in the European CWS-2002P and RMS 2005 Studies and the Soft Tissue Sarcoma RegistryAmadeus T Heinz, Melissa Ciuffolotti, Johannes H M Merks, et al.
BMJ Paediatrics Open|December 20, 2021
Transforming training into practice with the conflict management framework: a mixed methods studyOscar Lyons, Liz Forbat, Esse Menson, et al.
Pediatric Blood & Cancer|December 15, 2022
Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) reportFederico Mercolini, Johannes H M Merks, Veronique Minard-Colin, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Frontiers in Oncology|December 12, 2019
A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of RhabdomyosarcomasSusanne A Gatz, Ewa Aladowicz, Michela Casanova, et al.
Radiology|August 30, 2013
Response assessment in pediatric rhabdomyosarcoma: can response evaluation criteria in solid tumors replace three-dimensional volume assessments?Reineke A Schoot, Kieran McHugh, Rick R van Rijn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapyJulia C Chisholm, Julien Marandet, Annie Rey, et al.
Pediatric Blood & Cancer|May 6, 2016
Response Assessment in Paediatric Phase I Trials According to RECIST Guidelines: Survival Outcomes, Patterns of Progression and Relevance of Changes in Tumour MeasurementsFernando Carceller, Francisco J Bautista, Lucy A Fowkes, et al.
Annals of Surgery|June 1, 1974
The relationship of circulating endogenous endotoxin to hemorrhagic shock in the baboonC M Herman, A R Kraft, K R Smith, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|November 24, 1999
A standardized letter of recommendation for residency applicationS M Keim, J A Rein, C Chisholm, et al.
Pediatric Blood & Cancer|January 20, 2018
BRIM-P: A phase I, open-label, multicenter, dose-escalation study of vemurafenib in pediatric patients with surgically incurable, BRAF mutation-positive melanomaJulia C Chisholm, Jozef Suvada, Ira J Dunkel, et al.
Pediatric Blood & Cancer|December 10, 2024
Treatment of Pediatric, Adolescent, and Young Adult Patients With Fusion-Positive Alveolar Rhabdomyosarcoma Infiltrating Regional Lymph Nodes in the European CWS-2002P and RMS 2005 Studies and the Soft Tissue Sarcoma RegistryAmadeus T Heinz, Melissa Ciuffolotti, Johannes H M Merks, et al.
BMJ Paediatrics Open|December 20, 2021
Transforming training into practice with the conflict management framework: a mixed methods studyOscar Lyons, Liz Forbat, Esse Menson, et al.
Pediatric Blood & Cancer|December 15, 2022
Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) reportFederico Mercolini, Johannes H M Merks, Veronique Minard-Colin, et al.
Pageof 17